Taysha Gene Therapies, Inc.TSHANASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank83
3Y CAGR+57.5%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+57.5%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
3.9x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$9.77M+17.3%
2024$8.33M-46.1%
2023$15.45M+517.5%
2022$2.50M-
2021$0.00-
2020$0.00-
2019$0.00-